clinical trial · NCT02919995
A Study of RPL554 in Patients With Cystic Fibrosis
Cystic FibrosisRPL554Placebo
brief summary
This study evaluates two doses of RPL554 and placebo in adult patients with cystic fibrosis. All patients receive all three treatments in a randomised sequence.
started
Feb 8, 2017
primary completion
Nov 3, 2017
completion
Nov 3, 2017
last updated
May 21, 2024
official title
A Phase IIa, Randomised, Double Blind, Placebo Controlled, Three Way Crossover Study to Assess the Pharmacokinetics of RPL554 Administered to Adult Patients With Cystic Fibrosis.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol